BTMD · biote Corp
United States · RS rating 16 · As of 2026-11-03
| Price | 1.12 USD |
|---|---|
| 1-day change | -0.9% |
| RS rating (overall / 1M / 3M / 12M) | 16 / 56 / 9 / 16 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 14 / 6 / 14 |
| Industry group (rank) | Medical-Ethical Drugs (94) |
| EPS growth Q/Q | -72.7% |
| Sales growth Q/Q | -3.2% |
| Distance from 52-week high | +61.8% |
| Market cap (USD) | $71.1M |